Use of Sumor in the Antidepressant Therapy of Subjects With Major Depression: a Randomized Placebo-controlled Clinical Trial

Who is this study for? Patients with Major Depressive Disorder
What treatments are being studied? SUMOR
Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement, Other
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

Sumor is a food supplement that combines the main coenzymes of the S-Adenosyl methionine (SAMe) cycle, namely vitamins B6, B12 and folate, with SAMe and betaine. Sumor also contains vitamin C, a molecule that has shown promise in the treatment of depression in experimental models, and selenium, an antioxidant agent whose blood deficiency has been associated with depressive symptoms in some preliminary studies. There are no studies in the literature on the efficacy of this combination in the adjuvant therapy of depression. The purpose of this study is to compare the effects of Sumor in co-therapy with an SSRI antidepressant versus co-therapy with placebo in patients with treatment-resistant Major Depressive Disorder.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• Diagnosis of Major Depressive Disorder according to DSM-5 criteria

• Treatment-resistant status, assessed by clinical interview, after four weeks after SSRI therapy prescription as per NICE guidelines (National Institute for Health and Care Excellence, 2009)

• Age between 18 and 65 years

• Signature of informed consent

Locations
Other Locations
Italy
Azienda Ospedaliero Universitaria Careggi
RECRUITING
Florence
Contact Information
Primary
Valdo Ricca, MD
valdo.ricca@unifi.it
+390557947478
Time Frame
Start Date: 2021-06-01
Estimated Completion Date: 2024-06-01
Participants
Target number of participants: 102
Treatments
Placebo_comparator: Placebo
Experimental: SUMOR
Related Therapeutic Areas
Sponsors
Leads: Azienda Ospedaliero-Universitaria Careggi

This content was sourced from clinicaltrials.gov